Pradipta Ghosh
· ProfessorUniversity of California, San Diego · Cellular and Molecular Medicine
Active 1994–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Dr. Pradipta Ghosh is an Indian-born American physician-scientist, biochemist, and cell biologist with dual expertise in clinical medicine and basic research. She is a Professor in the Departments of Medicine and Cellular & Molecular Medicine at the University of California, San Diego, where she leads an innovative research group focused on cellular communication networks. Her pioneering work has significantly advanced the understanding of how intracellular heterotrimeric G-proteins are regulated by a novel family of guanine-nucleotide exchange modulators (GEMs), independently of traditional G-protein-coupled receptors (GPCRs). This groundbreaking research has uncovered new mechanisms of cell signaling with important implications for chronic diseases such as cancer, fibrosis, immunologic, and metabolic disorders. Ghosh's contributions have provided key insights into how intracellular communication is disrupted in disease, representing a conceptual breakthrough after prior attempts to unravel this network had failed. Recognizing the need for innovative tools to probe the laws governing cellular function, Dr. Ghosh founded the Institute for Network Medicine in 2018. This institute houses four transdisciplinary centers that synergistically work to uncover the unifying principles of cellular behavior, also known as invariants. These centers employ computational approaches, 3D cultures of human organoids and primary cells, advanced cell analysis techniques, and systems…
Research topics
- Biology
- Cell biology
- Medicine
- Computer Science
- Immunology
- Computational biology
- Biochemistry
- Chemistry
- Data science
- Neuroscience
Selected publications
Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19
eLife · 2021 · 131 citations
Background: SARS-CoV-2, the virus responsible for COVID-19, causes widespread damage in the lungs in the setting of an overzealous immune response whose origin remains unclear. Methods: We present a scalable, propagable, personalized, cost-effective adult stem cell-derived human lung organoid model that is complete with both proximal and distal airway epithelia. Monolayers derived from adult lung organoids (ALOs), primary airway cells, or hiPSC-derived alveolar type II (AT2) pneumocytes were inf…
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
Nature Communications · 2021 · 127 citations
The ongoing pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), necessitates strategies to identify prophylactic and therapeutic drug candidates for rapid clinical deployment. Here, we describe a screening pipeline for the discovery of efficacious SARS-CoV-2 inhibitors. We screen a best-in-class drug repurposing library, ReFRAME, against two high-throughput, high-content imaging infection assays: one using HeLa cells expressing SARS-CoV-2 receptor ACE2 and…
TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin
Proceedings of the National Academy of Sciences · 2020 · 103 citations
Senior authorCorrespondingSensing of pathogens by Toll-like receptor 4 (TLR4) induces an inflammatory response; controlled responses confer immunity but uncontrolled responses cause harm. Here we define how a multimodular scaffold, GIV (a.k.a. Girdin), titrates such inflammatory response in macrophages. Upon challenge with either live microbes or microbe-derived lipopolysaccharides (a ligand for TLR4), macrophages with GIV mount a more tolerant (hypo-reactive) transcriptional response and suppress proinflammatory cytokin…
MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
EBioMedicine · 2024-05-08 · 37 citations
articleOpen accessBACKGROUND: -DM) is characterised by rapidly progressive interstitial lung disease (ILD) and high mortality. MDA5 is an RNA sensor and a key pattern recognition receptor for the SARS-CoV-2 virus. METHODS: -DM outbreak. FINDINGS: Sixty new anti-MDA5+, but not other MSAs surged between 2020 and 2022, increasing from 0.4% in 2019 to 2.1% (2020), 4.8% (2021) and 1.7% (2022). Few (8/60) had a prior history of confirmed COVID-19, peak rates overlapped with regional SARS-COV-2 community positivity rate…
Proceedings of the National Academy of Sciences · 2020 · 36 citations
Senior authorCorrespondingThe molecular mechanisms by which receptor tyrosine kinases (RTKs) and heterotrimeric G proteins, two major signaling hubs in eukaryotes, independently relay signals across the plasma membrane have been extensively characterized. How these hubs cross-talk has been a long-standing question, but answers remain elusive. Using linear ion-trap mass spectrometry in combination with biochemical, cellular, and computational approaches, we unravel a mechanism of activation of heterotrimeric G proteins by…
Recent grants
Integrators of Metastatic Potential
NIH · $2.3M · 2019–2026
NIH · $3.2M · 2019–2031
Precision therapeutics of inflammatory bowel disease guided by Boolean logic
NIH · $937k · 2020–2023
Frequent coauthors
- 122 shared
Debashis Sahoo
University of California, San Diego
- 82 shared
Amer Ali Abd El‐Hafeez
Children Cancer Hospital
- 78 shared
Soumita Das
University of Massachusetts Lowell
- 49 shared
Jason Ear
California State Polytechnic University
- 40 shared
Ibrahim M. Sayed
University of Massachusetts Lowell
- 40 shared
Nicolas Aznar
Centre National de la Recherche Scientifique
- 38 shared
Gajanan D. Katkar
University of California, San Diego
- 35 shared
Saptarshi Sinha
University of California, San Diego
Similar researchers at University of California, San Diego
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Pradipta Ghosh
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
